Hawaii Bill to Expand Medical Cannabis Law Passes Senate Committee, Already Passed House

Legislation to expand Hawaii’s medical cannabis program has been passed by its initial Senate committee; it’s already passed the full House of Representatives.

House Bill 1488 was reported out of the Senate Commerce, Consumer Protection, and Health Committee today. Earlier this month it passed the full House of Representatives.

The proposed law would amend “the definition of “adequate supply” of marijuana to include seven marijuana seedlings”, and would amend “the definition of “debilitating medical condition” to include lupus, epilepsy, multiple sclerosis, arthritis, and autism as conditions that qualify for the legal use of medical marijuana.”

Read moreHawaii Bill to Expand Medical Cannabis Law Passes Senate Committee, Already Passed House

Hawaii Senate Votes Unanimously to Allow Medical Cannabis for Lupus, Epilepsy, Multiple Sclerosis, Arthritis and Autism

A Hawaii measure that would expand the list of qualifying medical cannabis conditions has been passed by the state’s full Senate.

Senate Bill 174 was passed today with a unanimous 25 to 0 vote. It now goes to the House of Representatives, where its passage will send it to Governor David Ige for consideration.

If passed into law, the proposal would allow those with lupus, epilepsy, multiple sclerosis, arthritis and autism to become registered medical cannabis patients, allowing them to possess, purchase (from a licensed dispensary) and use cannabis and cannabis products for medical use.

Read moreHawaii Senate Votes Unanimously to Allow Medical Cannabis for Lupus, Epilepsy, Multiple Sclerosis, Arthritis and Autism

Alabama Senate Judiciary Committee Approves Bill to Legalize Medical Cannabis

Legislationmedcannabis to legalize medical cannabis has been passed with a 4 to 3 vote by Alabama’s Senate Judiciary Committee. Senate Bill 326 now moves towards a full Senate vote.

If approved into law, the Alabama Medical Marijuana Patient Safe Access Act would allow those with a qualifying condition to possess up to 10 ounces of cannabis, and would allow them to purchase the medicine from state-licensed dispensaries. Conditions that qualify an individual to be a medical cannabis patient under SB 326 includes autism, anorexia, bipolar disorder, cancer, chronic pain, AIDS, ADD/ADHD, migraines, glaucoma, fibromyalgia, Parkinson’s disease, post traumatic stress disorder and obsessive-compulsive disorder.

Read moreAlabama Senate Judiciary Committee Approves Bill to Legalize Medical Cannabis

University of Alabama Receives FDA Approval to Produce, Administer and Study Cannabis Extracts

Cannabis tincture.
Cannabis tincture.

The University of Alabama has received approval from the Food and Drug Administration (FDA) to begin cultivating, administering and studying the impact of low-THC (tetrahydrocannabinol), high-CBD (cannabidiol) cannabis extracts on childhood and adult seizure disorders.

In April, Alabama Governor Robert Bentley signed into law Senate Bill 174 which authorizes the University of Alabama’s Department of Neurology to prescribe, produce and distribute low-THC cannabis extracts – such as cannabis oil and tinctures – to those with seizure disorders. The oil must be primarily CBD, and can contain no more than 3% THC.

Read moreUniversity of Alabama Receives FDA Approval to Produce, Administer and Study Cannabis Extracts

Alabama Governor Signs Medical Cannabis Bill Into Law

Alabama Governor Robert Bentley has signed Senate Bill 174, a medical cannabis proposal whichconsumecannabisdotcom was passed unanimously by the state’s House and Senate.

Under the new law, the University of Alabama’s Department of Neurology will be authorized to prescribe, produce and distribute low-THC cannabis extracts (such as cannabis oil and tincture) to those with seizure disorders.

Read moreAlabama Governor Signs Medical Cannabis Bill Into Law

Alabama Legislature Passes Bill to Establish Million Dollar Medical Cannabis Study, Goes to Governor

Alabama’s full Legislature has passed Senate Bill 174, a proposal to establish a study on the use of cannabis extract in treating seizure disorders.

tincture
Cannabis tincture.

The measure passed the Senate unanimously today, approving minor changes made by the House of Representatives (which also passed the bill unanimously); the measure now heads to Governor Robert Bentley, who can either sign the bill into law, let it become law without his signature, or veto it.

Read moreAlabama Legislature Passes Bill to Establish Million Dollar Medical Cannabis Study, Goes to Governor

Alabama Senate Unanimously Approves Million Dollar Study on Cannabis Oil

In a unanimous 34 to 0 vote, Alabama’s Senate passed Senate Bill 174 today,Alabama-sign sending it to the state’s House of Representatives.

The proposal – named Carly’s Law in honor of 3-year-old Carly Chandler who suffers from epilepsy – would allow the University of Alabama’s Department of Neurology to study the use of cannabis oil for the treatment of seizure disorders. The university would be authorized to prescribe and distribute low-THC cannabis oil to treat those with epilepsy; participants of the study would be provided complete protection from arrest.

Read moreAlabama Senate Unanimously Approves Million Dollar Study on Cannabis Oil